IBN Sina Pharmaceutical Industry plans to split up its natural medicine division and transfer it to the newly created IBN Sina Natural Medicine Limited, subject to shareholder approval at the company’s next annual general meeting.
IBN Sina Pharma now has two manufacturing facilities in its Gazipur facility. One unit generates pharmaceutical medicine, while the other produces natural medicine.
The assets and liabilities of the natural medicine unit will be transferred to IBN Sina Natural Medicine Limited. The natural medicine industry will be run by a subsidiary of IBN Sina Pharma. IBN Sina Pharma will be in charge of marketing and distribution.
Sources for more details: